Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2014-09-28 Major Shareholding Noti…
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Change in substantial holding - Amended 2 pages 297.7KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and shareholdings of a substantial shareholder, Bernard Stang, including dates and share quantities. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management information, but a regulatory disclosure about shareholding changes.
2014-09-28 English
EU study - trophon significantly more effective than wipes 1
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 17 September 2014 from Nanosonics Limited, discussing a new European study about the effectiveness of their trophon EPR disinfection technology compared to manual methods. It includes quotes from the CEO and references the study's presentation at a conference. The document is relatively short (3164 characters) and does not contain any financial data, regulatory filings, or detailed financial reports. It is an informational announcement about a study and product efficacy, not a financial report, management change, or regulatory filing. Therefore, it fits best under Regulatory Filings (RNS) as a general company announcement that does not fit other specific categories.
2014-09-16 English
Change in substantial holding 2 pages 475.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and shareholdings of a substantial shareholder, Bernard Stang, including dates and share quantities. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory filing specifically about shareholding changes.
2014-09-14 English
Appendix 3B 7 pages 118.4KB
Share Issue/Capital Change Classification · 100% confidence The document is an announcement dated 8 September 2014 from Nanosonics Limited regarding the exercise of options and the issue of shares under the company's General Share Option Plan. It includes detailed information about the number and class of securities issued, exercise prices, expiry dates, and compliance with relevant sections of the Corporations Act 2001. The document is structured as an Appendix 3B New Issue Announcement, which is a standard form used for notifying the Australian Securities Exchange (ASX) about new securities issued and their quotation. There are no financial statements, management discussion, or earnings data present. The document is primarily a regulatory announcement about capital changes (issuance of shares following option exercises). Therefore, it fits the category of Share Issue/Capital Change (SHA).
2014-09-07 English
Price Query and Response 4 pages 281.2KB
Regulatory Filings Classification · 100% confidence The document is a letter from ASX Compliance Pty Ltd to Nanosonics Limited regarding a price query about recent trading in the company's securities. The letter requests the company to confirm whether it is aware of any undisclosed information that could explain the trading activity and whether it is in compliance with ASX Listing Rules, particularly Listing Rule 3.1. The company's response confirms no undisclosed information and compliance with the rules. The document is a regulatory communication related to market disclosure and compliance, not a financial report, earnings release, or other specific report type. It is a regulatory filing responding to a compliance query from the stock exchange. Therefore, the appropriate classification is Regulatory Filings (RNS).
2014-09-01 English
2014 Full Year Results Investor Presentation 33 pages 4.3MB
Investor Presentation Classification · 95% confidence The document is titled '2014 Full Year Results Investor Presentation' and contains detailed financial results for the full year 2014, including revenue, gross profit, net loss, and segment highlights. It also includes company overview, market data, strategic partnerships, and product information. The content is structured as a presentation aimed at investors, focusing on financial performance, market position, and strategic updates. There is no indication that this is a full annual report filing (10-K), nor is it a brief earnings release or a regulatory announcement. The document is clearly a detailed investor presentation with financial and strategic information for the full year. Therefore, the appropriate classification is Investor Presentation (IP). The document length (15,000 characters) and content support this classification with high confidence.
2014-08-24 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.